A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status

Real World ◽

Brca Mutation ◽

Metastatic Breast ◽

Treatment Patterns ◽

Mutation Status ◽

Real World Evidence ◽

Germline Brca Mutation ◽

Inhibitor Treatment

Real-world clinical outcomes and treatment patterns among metastatic breast cancer (MBC) patients with germline BRCA mutation (gBRCAmut).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13075 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13075-e13075

Author(s):

Ruben Quek ◽

Jack Mardekian

Keyword(s):

Breast Cancer ◽

Clinical Outcomes ◽

Real World ◽

Brca Mutation ◽

Metastatic Breast ◽

Treatment Patterns ◽

Abstract PS7-82: A real-world evidence study of treatment patterns among patients with HER2-positive metastatic breast cancer

10.1158/1538-7445.sabcs20-ps7-82 ◽

2021 ◽

Author(s):

Jenna Collins ◽

Beth Nordstrom ◽

Jackie Kwong ◽

Brian Murphy ◽

Melissa Pavilack

Keyword(s):

Breast Cancer ◽

Real World ◽

Metastatic Breast ◽

Treatment Patterns ◽

Her2 Positive ◽

Real World Evidence

BREAKOUT: A cross-sectional, prospective, observational study of germline BRCA mutation (gBRCAm) prevalence and real-world outcomes among patients (pts) with HER2-negative (HER2-ve) metastatic breast cancer (mBC)

Annals of Oncology ◽

10.1093/annonc/mdx365.079 ◽

2017 ◽

Vol 28 ◽

pp. v105

Author(s):

T. Dalvi ◽

K.A. Gelmon ◽

R. Dent ◽

M. Pegram ◽

S. Loibl ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Real World ◽

Prospective Observational Study ◽

Brca Mutation ◽

Metastatic Breast ◽

Cross Sectional ◽

Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

European Journal of Cancer ◽

10.1016/s0959-8049(18)30285-5 ◽

2018 ◽

Vol 92 ◽

pp. S19-S20 ◽

Cited By ~ 3

Author(s):

E. Senkus-Konefka ◽

S.M. Domchek ◽

S.A. Im ◽

B. Xu ◽

A. Armstrong ◽

...

Keyword(s):

Breast Cancer ◽

Subgroup Analysis ◽

Hormone Receptor ◽

Brca Mutation ◽

Metastatic Breast ◽

Mutation Status ◽

Clinical outcomes, treatment patterns and health resource utilization (HRU) in triple negative metastatic breast cancer (mTNBC): a comparison between younger and older patients (pts) with germline BRCA mutation (gBRCAm)

The Breast ◽

10.1016/j.breast.2018.08.081 ◽

2018 ◽

Vol 41 ◽

pp. S28

Author(s):

Ruben G.W. Quek ◽

Jack Mardekian

Keyword(s):

Breast Cancer ◽

Older Patients ◽

Triple Negative ◽

Brca Mutation ◽

Metastatic Breast ◽

Treatment Patterns ◽

Health Resource ◽

Health Resource Utilization ◽

Clinical outcomes, treatment patterns and health resource utilization (HRU) among metastatic breast cancer (mbc) patients (pts) with germline BRCA mutation (gBRCAm)

Annals of Oncology ◽

10.1093/annonc/mdy272.300 ◽

2018 ◽

Vol 29 ◽

pp. viii98-viii99

Author(s):

R. Quek ◽

J. Mardekian

Keyword(s):

Breast Cancer ◽

Clinical Outcomes ◽

Resource Utilization ◽

Brca Mutation ◽

Metastatic Breast ◽

Treatment Patterns ◽

Health Resource ◽

Health Resource Utilization ◽

A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation

Case Medical Research ◽

10.31525/ct1-nct04296370 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Brca Mutation ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Chemotherapy Treatment ◽

116P Real-world treatment patterns and clinical effectiveness of eribulin in HR+/HER2- metastatic breast cancer patients in the United States

Annals of Oncology ◽

10.1016/j.annonc.2021.03.130 ◽

2021 ◽

Vol 32 ◽

pp. S72

Author(s):

S.S. Mougalian ◽

J. Zhang ◽

J.K. Kish ◽

M.E. Zettler ◽

B.A. Feinberg

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Real World ◽

Metastatic Breast ◽

Clinical Effectiveness ◽

The United States ◽

Treatment Patterns ◽

Breast Cancer Patients

Efficacy of First Line Regimens in Metastatic Breast Cancer Patients. Real World Evidence from Instituto Nacional de Cancerologia, Mexico City

The Breast ◽

10.1016/s0960-9776(17)30699-9 ◽

2017 ◽

Vol 36 ◽

pp. S50

Author(s):

Maria Tereza Nieto-Coronel ◽

Claudia Arce Salinas ◽

Ariana Tabares ◽

Jose Luis Aguilar-Ponce

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Mexico City ◽

Real World ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Real World Evidence

Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer

PharmacoEconomics ◽

10.1007/s40273-016-0411-2 ◽

2016 ◽

Vol 34 (10) ◽

pp. 1039-1050 ◽

Cited By ~ 7

Author(s):

Bonny Parkinson ◽

Rosalie Viney ◽

Marion Haas ◽

Stephen Goodall ◽

Preeyaporn Srasuebkul ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Real World ◽

Metastatic Breast ◽

Her2 Positive ◽

Real World Evidence